DOPAVISION

dopavision-logo

Dopavision is a therapeutic company developing a digital therapeutic for myopia. Myopia, or shortsightedness, is a condition where the visual image is focused in front of the retina, instead of on the retina itself, as it should. People with myopia have good near sight vision but poor distance vision. Dopavision is developing a digital therapeutic for myopia which can be seamlessly and invisibly integrated with the use of a smartphone. Myopia is a visual condition that affects on average every t... hird person globally, a share that has increased rapidly during the last two decades. The goal of the Berlin-based startup is to develop a clinically validated therapy for myopia progression in children and adolescents. The technology delivers light stimulation to specific photosensitive cells on the retina which in turn modulate dopamine, a neurotransmitter that is important for the regulation of eye growth. Founded in 2017, Dopavision GmbH is supported by the German government via the โ€œIndustrie-in-Klinikโ€ program of the BMBF (Federal Ministry of Education and Research) with the amount of โ‚ฌ 1.4 million over three years.

#SimilarOrganizations #People #Financial #Event #Website #More

DOPAVISION

Social Links:

Industry:
Biotechnology Health Care Medical Device Therapeutics

Founded:
2017-01-01

Address:
Berlin, Berlin, Germany

Country:
Germany

Website Url:
http://www.dopavision.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
13.2 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag


Similar Organizations

kvatchii-logo

Kvatchii

Kvatchii is developing a truly patient-focused deep health digital platform from ground-up in India.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.


Current Advisors List

annegret-de-baey_image

Annegret de Baey Advisory Board @ Dopavision
Advisor
2021-07-14

stefan-zundel_image

Stefan Zundel Co-founder and member of the Advisory Board @ Dopavision
Board_member
2022-05-01

Current Employees Featured

hamed-bahmani_image

Hamed Bahmani
Hamed Bahmani Founder and Managing Director @ Dopavision
Founder and Managing Director
2017-10-01

mark-wuttke_image

Mark Wuttke
Mark Wuttke Chief Executive Officer @ Dopavision
Chief Executive Officer
2022-04-01

Founder


hamed-bahmani_image

Hamed Bahmani

stefan-zundel_image

Stefan Zundel

Investors List

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Series A - Dopavision

seventure-partners_image

Seventure Partners

Seventure Partners investment in Series A - Dopavision

ababax-health_image

Ababax.Health

Ababax.Health investment in Series A - Dopavision

drx-capital_image

dRx Capital

dRx Capital investment in Series A - Dopavision

novartis-pharma_image

Novartis Pharma

Novartis Pharma investment in Series A - Dopavision

ralf-meister_image

Ralf Meister

Ralf Meister investment in Seed Round - Dopavision

flyinghealth_image

Flyinghealth

Flyinghealth investment in Seed Round - Dopavision

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Seed Round - Dopavision

Key Employee Changes

Date New article
2022-05-25 Dopavision Appoints Mark S. Wuttke, Ph.D., as Chief Executive Officer

Official Site Inspections

http://www.dopavision.com

  • Host name: wp1.swpress.de
  • IP address: 213.133.103.236
  • Location: Nuremberg Germany
  • Latitude: 49.4475
  • Longitude: 11.0683
  • Timezone: Europe/Berlin
  • Postal: 90409

Loading ...

More informations about "Dopavision" on Search Engine